Thrombosis management in times of COVID-19 epidemy; a Dutch perspective

Hugo ten Cate

doi:10.1186/s12959-020-00220-3

Thrombosis management in times of COVID-19 epidemy; a Dutch perspective

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

Original language	English
Article number	7
Number of pages	2
Journal	Thrombosis Journal
Volume	18
Issue number	7
DOIs	https://doi.org/10.1186/s12959-020-00220-3
Publication status	Published - 20 Apr 2020

Access to Document

10.1186/s12959-020-00220-3Licence: CC BY

Cite this

@article{dbae7d293c0a43729b7d6184de0611c0,

title = "Thrombosis management in times of COVID-19 epidemy; a Dutch perspective",

author = "{ten Cate}, Hugo",

note = "Funding Information: Hugo ten Cate is chairman of the board of the Dutch Federation of Anticoagulation clinics. His research is supported in part by grants from Bayer and Pfizer. He is shareholder of Coagulation Profile and consultant for Aleveron.",

year = "2020",

month = apr,

day = "20",

doi = "10.1186/s12959-020-00220-3",

language = "English",

volume = "18",

journal = "Thrombosis Journal",

issn = "1477-9560",

publisher = "BioMed Central Ltd",

number = "7",

}

TY - JOUR

T1 - Thrombosis management in times of COVID-19 epidemy; a Dutch perspective

AU - ten Cate, Hugo

N1 - Funding Information: Hugo ten Cate is chairman of the board of the Dutch Federation of Anticoagulation clinics. His research is supported in part by grants from Bayer and Pfizer. He is shareholder of Coagulation Profile and consultant for Aleveron.

PY - 2020/4/20

Y1 - 2020/4/20

U2 - 10.1186/s12959-020-00220-3

DO - 10.1186/s12959-020-00220-3

M3 - Editorial

C2 - 32336956

SN - 1477-9560

VL - 18

JO - Thrombosis Journal

JF - Thrombosis Journal

IS - 7

M1 - 7

ER -